Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

New therapies are being developed that target integrin pathways to treat various diseases.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Chicken feather gene mutation helps understand human hair disorders.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Minoxidil can reduce functions related to androgen receptors.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.